International Journal of Antimicrobial Agents

Article	Citations
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	94
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems	80
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms	75
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen	64
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	63
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis	61
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings	59
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients	57
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr	55
Title Page & Editorial Board	55
Characterisation of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol	50
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	46
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	45
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	44
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	44
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans	44
Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China	43
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota	42
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho	40
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria	37
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis	36
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis	36
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure	35
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis	35
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia	34

Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy	34
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo	33
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae	33
LightCPPgen: An Explainable Machine Learning Pipeline for Rational Design of Cell Penetrating Peptides	33
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen	31
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting	31
Antibiotic resistance in Enterobacter hormaechei	30
Variability in oral antibiotic step-down therapy in the management of Gram-negative bloodstream infections	29
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance	29
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae	29
Resistance of Gram-negative bacteria to aztreonam-avibactam: An evaluation of data from in vitro studies	28
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect	28
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases	27
Alterins, a new family of marine antibacterial cyclolipopeptides	27
Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents	27
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors	26
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	26
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae	26
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci	26
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and	26
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae	26
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference	25
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis	25
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:	25
Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV	25
Individualised amoxicillin-clavulanate dosing recommendations for critically ill children with augmented clearance after cardiac surgery	24
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant	24
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections	24
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor	24
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection	24
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii	24
Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap	23
MRSA surveillance programmes worldwide: moving towards a harmonised international approach	23
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice	22
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance	22
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re	22
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients	22
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study	22
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce	21
Title Page & Editorial Board	21
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study	21
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis	21
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel	21
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals	21
Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae	21
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans， coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity	21
Large scale laboratory evolution uncovers clinically relevant collateral antibiotic sensitivity	20
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study	20
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen	20
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	20

Title Page & Editorial Board	20
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	20
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli	20
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report	20
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy	20
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines	20
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China	20
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?	20
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis	19
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing	19
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy	19
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools	19
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus	19
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations	19
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia	19
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based	19
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan	19
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa	19
High diversity of blaNDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital	19
NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Title Page & Editorial Board	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates	18
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria	18
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan	18
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)	18
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis	18
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and	18
Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?	17
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study	17
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa	17
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series	17
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion	17
Rising threat of metallo-β-lactamase-producing Klebsiella oxytoca complex in Taiwan, 2013–2022	16
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae	16
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece	16
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function	16
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses	16
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient	16
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study	16
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker	16
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study	16
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI	16
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials	16
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial	16
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies	16
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification	16
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data	16
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial	16
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis	16
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis	16
Human tissue distribution of caspofungin	16
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration	16
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study	16
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli	16
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals	15
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model	15
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem	15
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance	15
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain	15
In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam	15
The dlt operon contributes to the resistance to chlorhexidine in Streptococcus mutans	15
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment	15
Pharmacodynamic Insights to Support Pneumonia Treatment in a Patient Co-Infected with Two Carbapenem-Resistant Bacteria	15
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan	15
New options for bloodstream infections caused by colistin‐ or ceftazidime/avibactam‐resistant Klebsiella pneumoniae	15
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future	15
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus	15
The antimicrobial activity of innate host-directed therapies: A systematic review	14
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam	14
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218	14
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses	14
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience	14
Intravenous to oral antibiotics versus intravenous antibiotics: a step-up or a step-down for extended spectrum β-lactamase (ESBL)-producing urinary tract infections without concomitant bacteraemia?	14
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis	14
Cellular and genetic changes during and after fluconazole exposure in Cryptococcus neoformans	14
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus	14
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns	14
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme	14

Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii	14
Letter to the Editor: Comment to ‘Assessment of Dientamoeba fragilis interhuman transmission by faecal microbiota transplantation’ by Moreno-Sabater et al. (2025)	14
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes	13
Reviewer Thank you List 2021	13
Title Page & Editorial Board	13
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis	13
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?	13
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis	13
Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections	13
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O	13
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study	13
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade	13
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat	13
Pattern and appropriateness of antibiotic prescriptions for upper respiratory tract infections in primary care paediatric patients	13
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals	13
Title Page & Editorial Board	13
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance	13
A translational rat model to assess glomerular function changes with vancomycin	13
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis	13
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit	13
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights	12
Clonal outbreak of NDM-1-producing Enterobacter hormaechei belonging to high-risk international clone ST78 with the coexistence of tmexCD2-toprJ2 and mcr-9 in China	12
Identification of a multi-replicon plasmid co-harboring mcr-1 and tmexCD3-toprJ1 in Escherichia coli ST101 isolated from wastewater in South Korea	12
MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus	12
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients	12
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability	12
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin	12
Efficacy of a bacteriophage cocktail (Arash and Ariobarzanes) in the treatment of Salmonella typhimurium infection in a rat model	12
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020	12
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing	12
Unveiling the clonal dynamics and transmission mechanism of carbapenem-resistant Klebsiella pneumoniae in the ICU environment	12
Clinical application of customized and non-customized bacteriophage therapy in patients with refractory/resistant bacterial infections: A systematic review and meta-analysis	12
A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects	12
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria	12
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan	12
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics	12
Title Page & Editorial Board	12
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico	12
Development of multiplex recombinase polymerase amplification for the rapid detection of five carbapenemase (blaKPC, blaNDM, blaOXA-48-like, blaIMP, and blaVIM) and 10 mcr (mcr-1 to mcr-10) genes in b	12
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial	12
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration	12
Epidemiology, Treatment and Outcomes of Bloodstream Infections Due to MBL-Producing Enterobacterales in France: A Retrospective Study	12
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae	12
Phylogenetic insights of a human-derived optrA-positive Staphylococcus aureus isolated from a person with chronic diarrhea in China	12
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales	12
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis	12
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance	12
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis	12
Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a ‘One Health’ study	12
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity	12
Blockade of pan-viral propagation by inhibition of host cell PNPT1	12
Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population	11
Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia	11
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study	11
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification	11
Systematic review of disulfiram as an antibacterial agent: what is the evidence?	11
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis	11
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents	11
Emergence of a clinical carbapenem-resistant Escherichia coli co-harboring blandm-5 and mcr-1.1 on the same plasmid	11
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis	11
Exploration of the optimal GS-441524 trough concentration for treating COVID-19	11
Efficacy of adding azithromycin to antibiotic prophylaxis in caesarean delivery: a meta-analysis and systematic review	11
Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing	11
Phage therapy combats pan drug-resistant Acinetobacter baumannii infection safely and efficiently	11
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections	11
Recommended Antibiotic Dosage Regimens in Critically Ill Patients with Augmented Renal Clearance: A Systematic Review	11
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model	11
Title Page & Editorial Board	11
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020	11
Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid	11
HISTORY OF THE INTERNATIONAL SOCIETY OF ANTIMICROBIAL CHEMOTHERAPY (ISAC)	11
Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice	11
Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae	10
Metagenomics next-generation sequencing (mNGS) reveals emerging infection induced by Klebsiella pneumoniaeniae	10
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique	10
Intravenous combined with aerosolised polymyxins vs intravenous polymyxins monotherapy for ventilator-associated pneumonia: A systematic review and meta-analysis	10
Challenges and potential solutions for cycloserine dosing in patients with sepsis undergoing continuous renal replacement therapy	10
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling	10
Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies	10
Genomic characterisation of a novel KPC-98-producing clinical Klebsiella pneumoniae strain conferring resistance to ceftazidime/avibactam	10
Combined treatment of Japanese spotted fever with tetracycline and fluoroquinolone requires careful evaluation using robust outcomes both in terms of its advantages and disadvantages	10
Emergence of chromosomally located blaCTX-M-14b and qnrS1 in Salmonella enterica serotype Kentucky ST198 in China	10
Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: Driven by KPC-2 and OmpK36 mutations	10
Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams	10
Typology of interventions for antimicrobial use and antimicrobial resistance in aquaculture systems in low- and middle-income countries	10
Polymyxin causes cell envelope remodelling and stress responses in mcr-1-harbouring Escherichia coli	10
In reply to comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicenter, prospective, cluster r	10
Evaluation of penicillin‐gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis	10
In vitro activity of imipenem/relebactam plus aztreonam against metallo-β-lactamase-producing, OprD-deficient Pseudomonas aeruginosa with varying levels of Pseudomonas-derived cephalosporinase product	10
Title Page & Editorial Board	10
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid	10
Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia	10
Reversible vancomycin susceptibility within emerging ST1421 Enterococcus faecium strains is associated with rearranged vanA-gene clusters and increased vanA plasmid copy number	10
Screening patients at admission to Copenhagen hospitals for carriage of resistant bacteria after contact with healthcare systems abroad, 2016–2019	10
Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria	10